BGC4
BGC4 is a biphenyl-based gold (III) complex. BGC4 inhibits human recombinant thioredoxin reductase (TrxR) with an IC50 of 10.7 μM, exhibits cytotoxicity (IC50 for MDA-MB-231 is 5.4 μM), and induces apoptosis. BGC4 exhibits antitumor efficacy in mouse models[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; TrxR
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC(C)(C1=CC2=C(C=C1)C3=CC=C(C=C3[Au]2(C4N(C=CN4C5=NC=CC(C(F)(F)F)=C5)C)Cl)C(C)(C)C)C
Molecular Formula
C30H33AuClF3N3
Molecular Weight
725.02
References & Citations
[1]Remadna E, et al., Synthesis and Biological Evaluation of a New Biphenyl-Based Organogold (III) Complex with In Vitro and In Vivo Anticancer Activity. J Med Chem. 2025 Jan 23;68 (2) :1755-1771.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
303319 100 µg
GAD67, CT (67kD Glutamic Acid Decarboxylase, DCE1, DCE1_HUMAN, EC 4.1.1.15, GAD 1, GAD 67, GAD, GAD-67, GAD1, GADA, Glutamate Decarboxylase 1 (Brain 67kD), Glutamate Decarboxylase 1, Glutamate Decarboxylase 1 Brain 67kD, Glutamate Decarboxylase 1 Brain 67kD, Glutamate Decarboxylase 67kD Isoform, SCP)
Ask
View Details 